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“Stephen Hunter is a bona fide 
triple threat.  He’s an outstanding 
clinician, is the Associate Director 
of the Iowa Statewide Perinatal 
Care Program, and maintains a 
high-quality research program.” 





One of Dr. Hunter’s passions 
as a physician is to prevent 
preterm births. He believes 
the physician’s role is to be 
an advocate for both the 
mother and the unborn child. 
 
Board Member Spotlight: 
Stephen K. Hunter, MD, PhD 
 
With a BS degree in Engineering, a PhD 
in Pharmaceutics, and passion for 
perinatal outreach, Dr. Stephen Hunter 
is not the typical physician scientist. 
According Dr. Kimberly Leslie, Head of 
Obstetrics and Gynecology at the 
University of Iowa, “Stephen Hunter is a 
bona fide triple threat. He’s an 
outstanding clinician, is the Associate 
Director of the Iowa Statewide Perinatal 
Care Program, and maintains a high-
quality research program.”  
 
Dr. Hunter received a BS degree in 
Materials Science and Engineering from 
the University of Utah in 1982.  His first 
insight into the power of translational 
research came that same year when 
Barney Clark was the first human 
implanted with an artificial heart at the 
University of Utah. At that time, Dr. 
Hunter was working there with the 
artificial heart team in the Division of 
Artificial Organs, so this landmark 
medical achievement was of particular 
importance to him.  Because of his 
interest in research, he continued his 
academic pursuits and received a PhD 
in the Department of Pharmaceutics at 
the University of Utah in 1987.  For his 
PhD dissertation, he developed an 
artificial fallopian tube that could be 
used for fertility treatments because, at 
the time, in vitro fertilization was still in 
its infancy. Dr. James Scott, who was 
the chair of the Department of 
Obstetrics and Gynecology and a 
member of his PhD committee, became 
one of Dr. Hunter’s first and greatly 
admired mentors. According to Dr. 
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Hunter, he learned from Dr. Scott the 
importance of providing the best care 
you can to patients. Dr. Scott is now the 
Editor-in-Chief of the Green Journal 
(aka Obstetrics & Gynecology), the 
largest obstetrics journal in the country. 
While Dr. Hunter’s research program 
has moved beyond generation of 
artificial organs, some aspects of his 
PhD research can still be seen in one of 
his current research endeavors – using 
tissue engineering to treat maternal 
phenylketonuria (PKU) syndrome. 
 
After completing his PhD and MD at the 
University of Utah, Dr. Hunter moved to 
the University of Iowa in 1989 for a 
residency in Obstetrics and Gynecology. 
He went on to complete his Maternal-
Fetal-Medicine fellowship at Iowa and 
joined the ranks of faculty in 1996 as an 
Assistant Professor in the Departments 
of Obstetrics and Gynecology, Chemical 
and Biochemical Engineering, and 
Biomedical Engineering. He is now a full 
professor of Obstetrics and Gynecology.  
In November 2010, he was appointed to 
Director of the Division of Maternal and 
Fetal Medicine (MFM). Of note, Dr. 
Hunter was recently bestowed with the 
National Perinatal Association’s 2009 
Individual Contribution to Maternal and 
Child Health Award. This award is to 
honor an individual who has worked 
tirelessly to enhance the maternal and 
child health cause.  
 
One of Dr. Hunter’s passions as a 
physician is to prevent preterm births. 
He believes the physician’s role is to be 
an advocate for both the mother and the 
unborn child. Dr. Hunter long-standing 
commitment to perinatal care led him to 
become a part of the Iowa Statewide 
Perinatal Care Program in 2005 as 
Associate Director and MFM specialist. 
He assumed this position when the 
previous Associate Director, Dr. Frank 
Zlatnik, retired. According to Dr. Hunter, 
it was a great honor when Dr. Zlatnik 
asked him to take over his position with 
the program, particularly since he 
considers Dr. Zlatnik to be another of his 
greatest mentors. The mission of the 
Iowa Statewide Perinatal Care Program 
is to review the obstetrics programs in 
every hospital in Iowa, of which there 
are currently 80, to ensure high quality 
care to mothers and children and 
maintain a regionalized care pattern in 
the State of Iowa. The primary focus of 
the program is on quality and safety 
issues, particularly to eliminate elective 
inductions earlier than 39 gestational 
weeks. Dr. Hunter is also the March of 
Dimes Iowa State Prematurity Chair, 
which clearly demonstrates his 
commitment to high-quality perinatal 
care in Iowa.  
 
In his research program, Dr. Hunter 
leverages the knowledge he gained with 
his degrees in engineering and 
pharmaceutics to develop nanoparticle 
targeted therapies and vaccines. His 
research program has three main 
focuses: preeclampsia, Group B 
Streptococci vaccine development, and 
tissue engineering to treat maternal 
PKU syndrome. In addition to the 
deleterious consequences of infant 
infection with Group B Streptococci 
during birth, some evidence indicates 
that Group B strep may also increase 
the risk of preterm birth. Therefore, a 
vaccine would have a multitude of 
benefits to the infant. He is also 
interested in applying tissue engineering 
technology to develop treatments for 
maternal PKU syndrome. This 
syndrome is characterized by an 
inability to process the essential amino 
Proceedings in Obstetrics and Gynecology, 2011 April; 1(3):10 
 
  3 
 
acid phenylalanine into tyrosine; 
phenylalanine crosses the placenta and 
results in birth defects. The current 
treatment for maternal PKU syndrome is 
removing phenylalanine from the diet, 
which is both difficult and expensive. Dr. 
Hunter’s goal is to devise a new method 
to restore the enzyme that converts 
phenylalanine to tyrosine, phenylalanine 
hydroxylase.  
 
In addition to his responsibilities with a 
research lab and the perinatal outreach 
program, Dr. Hunter was recently 
appointed Director of the MFM Division 
in the Department of Obstetrics and 
Gynecology. His immediate goals are to 
expand the division by hiring new faculty 
members and increasing extramural 
funding for research. His vision for the 
division is to set a standard of safety 
and quality of care for the rest of the 
state to follow. 
Dr. Hunter still strives to maintain 
balance in his life. He continues to teach 
young physicians about the importance 
of patient care. One of his favorite 
questions to ask is, “What is the most 
important exam you’ll ever take?” 
According to Dr. Hunter, the responses 
are normally medical boards, but he 
strongly believes that the patient lying 
before you is the most important exam 
you’ll ever take – “if you flunk that exam, 
someone pays the price, and it’s not 
you.” Finally, family remains the most 
important thing in his life. Dr. Hunter 
believes that his greatest 
accomplishments are not listed on his 
CV, but within the walls of his home.  
 
Written by Kristina W. Thiel 
Scientific Associate Editor 
Proceedings in Obstetrics and Gynecology 
 
 
 
 
 
 
